- In April 2023, Bruker Corporation expanded its high-performance multiphoton microscopy portfolio with the release of the Ultima 2Pplus platform, designed to deliver deeper, faster, and clearer imaging of neural activity in live tissues. This development emphasizes Bruker's ongoing commitment to advancing neurophotonics tools that support cutting-edge research in brain function and neurological disease, enhancing imaging precision for real-time cellular studies in both academic and clinical environments
- In March 2023, Thorlabs Inc. announced the launch of its new turnkey femtosecond laser system tailored for two-photon excitation microscopy. The system integrates seamlessly with Thorlabs' imaging platforms, providing high stability and ease of use for neuroimaging applications. This innovation reflects Thorlabs' dedication to expanding access to advanced neurophotonics technologies for neuroscience labs worldwide
- In February 2023, Neurophotometrics Ltd. introduced its enhanced optical imaging system combining fiber photometry with machine-learning-based data analytics. This system enables researchers to monitor large-scale neural activity in freely moving animals with increased resolution and efficiency. The innovation underscores the growing demand for mobile, high-throughput neurophotonics solutions in behavioral neuroscience studies
- In January 2023, NIRx Medical Technologies collaborated with a leading European university to deploy its portable fNIRS systems for use in clinical trials targeting early detection of cognitive decline. This partnership highlights the expanding role of functional near-infrared spectroscopy in diagnostics and its increasing adoption in decentralized healthcare research.
- In January 2023, Inscopix Inc., a pioneer in miniature microscopy, launched its upgraded nVoke® system, integrating calcium imaging and optogenetics in a compact form for in vivo brain research. The release marks a significant step toward all-in-one neurophotonics platforms that facilitate real-time observation and manipulation of neural circuits, driving forward studies in neuropsychiatric and neurodegenerative disorders
